Related Experiment Video
Updated: May 9, 2026

08:22
Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
Fabrication and Characterization of a Surface-Acoustic-Wave Biosensor in CMOS Technology for Cancer Biomarker
IEEE Transactions on Biomedical Circuits and Systems
|July 16, 2013
Summary
A novel complementary metal-oxide semiconductor (CMOS) surface acoustic wave (SAW) biosensor was developed for early breast cancer detection. This cost-effective biosensor demonstrates high sensitivity and specificity for the mammoglobin (hMAM) biomarker in serum.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Early detection of breast cancer is crucial for improving patient outcomes.
- Existing diagnostic methods often lack the required sensitivity, specificity, or cost-effectiveness.
- There is a need for advanced biosensing technologies to detect cancer biomarkers in serum.
Purpose of the Study:
- To design, fabricate, and characterize a novel surface acoustic wave (SAW) biosensor integrated with complementary metal-oxide semiconductor (CMOS) technology.
- To develop a sensitive and specific immunoassay for detecting the breast cancer biomarker mammoglobin (hMAM).
- To evaluate the performance of CMOS-SAW devices as a cost-effective alternative for biosensing applications.
Main Methods:
- Development of two CMOS-SAW biosensor architectures (circular and rectangular).
- Implementation of a five-layer streptavidin/biotin-based immunoassay for hMAM detection.
- Characterization of sensor performance, focusing on center frequency shifts for sensitivity analysis.
- Selectivity testing against bovine serum albumin.
Main Results:
- Achieved a frequency sensitivity of 8.704 pg/Hz and a mass sensitivity of 2810.25 m²/kg.
- Demonstrated successful attachment of cancer biomarkers to functionalized sensor surfaces.
- Confirmed selective detection of hMAM antigens with high sensitivity and specificity.
- Observed improved repeatability of fabrication compared to existing technologies.
Conclusions:
- CMOS-SAW biosensors offer a promising platform for sensitive and specific detection of breast cancer biomarkers.
- The developed immunoassay enables early detection, prognosis, and therapy monitoring for breast cancer.
- This technology presents a viable, low-cost alternative to current biosensor systems with enhanced performance.
